2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureTheresa A. McDonagh, Robert J. Mentz, Marco Metra et al.|European Heart Journal|2023Cited by 2.2k
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 DiabetesRury R. Holman, Adrian F. Hernandez, M. Angelyn Bethel et al.|New England Journal of Medicine|2017Cited by 2.1k
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trialAdriaan A. Voors, Piotr Ponikowski, Christiane E. Angermann et al.|Nature Medicine|2022Cited by 889
Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysisM. Angelyn Bethel, Rury R. Holman, Rishi Patel et al.|The Lancet Diabetes & Endocrinology|2017Cited by 591
Noncardiac Comorbidities in Heart Failure With Reduced Versus Preserved Ejection FractionRobert J. Mentz, Christopher M. O’Connor, Dan Atar et al.|Journal of the American College of Cardiology|2014Cited by 541